Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00565643 · ClinicalTrials.gov registry record · Phase 4
Seprafilm® Adhesion Barrier and Cesarean Delivery
A Phase 4 study of Cesarean Section and Delivery, Obstetric, sponsored by Winthrop University Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 753
- Enrollment target
- 3
- Study locations
NCT00565643: Completed Phase 4 study of Cesarean Section and Delivery, Obstetric, sponsored by Winthrop University Hospital.
NCT00565643 is a Phase 4 study of Cesarean Section and Delivery, Obstetric that has completed, run by Winthrop University Hospital. The registered enrollment target is 753 participants, above the 117-participant average among 14 other Cesarean Section trials with a reported enrollment target (544% higher). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00565643, a Phase 4 study of Cesarean Section and Delivery, Obstetric, has completed, sponsored by Winthrop University Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 753 participants
- Enrollment target
- 3
- Study locations
Study Summary
A multicenter, randomized, controlled, single blinded study to evaluate the effectiveness of Seprafilm® Adhesion Barrier in reducing adhesion formation in cesarean deliveries. Primary outcome will be measurement of the extent and severity of adhesions at the time of subsequent cesarean delivery. Secondary outcomes will include measures of safety, operative times (ex., incision-delivery; total operative time).
Primary Outcome
The Percentage of participants with one or more adhesions, regardless of the extent or severity
Conditions Studied
Interventions
- DEVICE Placebo
- DEVICE modified sodium hyaluronic acid and carboxymethylcellulose
Study Locations (3)
New York
- Winthrop University Hospital - Mineola
- SUNY Stony Brook University Hospital - Stony Brook
Pennsylvania
- Lehigh Valley Hospital - Allentown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 753 participants |
| Start Date | 2007-11 |
| Est. Completion | 2014-10 |
| Phase | Phase 4 |
What the finished NCT00565643 record still lists
NCT00565643 is an interventional study that assigns participants to a tested intervention. The registered 753 participants enrollment target is mid-sized for trials with a published cap, above the 117-participant average among 14 other Cesarean Section trials with a reported enrollment target (544% higher).
The record links to 3 conditions, with Cesarean Section appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00565643 reports a single indexed study location in New York, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00565643 about?
NCT00565643 is a clinical study titled "Seprafilm® Adhesion Barrier and Cesarean Delivery". A multicenter, randomized, controlled, single blinded study to evaluate the effectiveness of Seprafilm® Adhesion Barrier in reducing adhesion formation in cesarean deliveries. Primary outcome will be measurement of the extent and severity of adhesions at the time of subsequent cesarean delivery. Sec...
What is the current status of trial NCT00565643?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 753 participants. The study started on 2007-11. Estimated completion is 2014-10.
What conditions does trial NCT00565643 study?
This clinical trial studies the following conditions: Cesarean Section, Delivery, Obstetric, Adhesions.
What interventions are being tested in trial NCT00565643?
The interventions under investigation include: Placebo (DEVICE), modified sodium hyaluronic acid and carboxymethylcellulose (DEVICE).
Who is sponsoring clinical trial NCT00565643?
This trial is sponsored by Winthrop University Hospital, which has 32 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00565643 being conducted?
This trial has 3 study locations across New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cesarean Section
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00565643's enrollment target sits among peer trials
753 1st of 14 higher than 14 of 14 other Cesarean Section trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cesarean Section trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Intrathecal Dexmedetomidine vs Epinephrine
RECRUITING · Phase 4
-
Intrathecal Opioids for Pain Control After Cesarean Delivery: Determining the Optimal Dose
COMPLETED · Phase 4
-
Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study
COMPLETED · Phase 4
-
Transcutaneous Electrical Nerve Stimulation for Post-Cesarean Pain Control
RECRUITING · NA
-
Post-operative Cesarean Trial of Pain Control
RECRUITING · NA
-
A Comparison of Manual vs. Spontaneous Removal of the Placenta at Cesarean Section
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05379985 · 754 participants · Phase 1
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- NCT05427370 · 754 participants · NA
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
- NCT06559306 · 752 participants · Phase 3
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- NCT05869149 · 756 participants · NA
Systems Science Approaches to Improve Access to Healthier Foods: The FRESH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia